Listed by the USPTO as HUPCZEY, JR, RONALD JAMES
Tech Center 3700 • Art Units: 3739 3794
This examiner grants 65% of resolved cases
HUPCZEY, JR, RONALD JAMES is assigned to art unit 3739 in tech center 3700, with 821 resolved cases. The allowance rate is 64.8%, and the median time to allowance is 1459 days. The record combines a moderate allowance outcome with a lengthy median prosecution period, making timing an important portfolio consideration.
The interview lift is 22.3%, a meaningful signal alongside the 64.8% allowance rate. Interview planning may be useful when paired with focused claim amendments and an early assessment of prosecution objectives. The listed companies are Biosense Webster (Israel) Ltd., Boston Scientific Corporation, and Medtronic Inc. The listed firms are Troutman Pepper Locke LLP, Nelson Mullins Riley & Scarborough LLP, and Alleman Hall LLP.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19013287 | INFLOW AND OUTFLOW CONTROL OF A CLOSED COOLING SYSTEM | Non-Final OA | Covidien LP |
| 19008488 | SYSTEMS, DEVICES, AND METHODS FOR SIGNAL GENERATION | Non-Final OA | Boston Scientific Scimed, Inc. |
| 18735972 | SURGICAL INSTRUMENTS HAVING A JAW LOCKING MECHANISM | Non-Final OA | Intuitive Surgical Operations, Inc. |
| 18946456 | PERICARDIAL TRANSECTION DEVICE WITH SUCTION DEVICE | Final Rejection | EDWARDS LIFESCIENCES CORPORATION |
| 18160277 | EGM FREQUENCY ANALYSIS FOR LESION EVALUATION | Non-Final OA | Medtronic, Inc. |
| 18931771 | ACCURATE POSITIONING AND SHAPE VISUALIZATION OF BALLOON CATHETER ABLATION TAGS | Final Rejection | Biosense Webster (Israel) Ltd. |
| 18510180 | FRACTAL CYLINDRICAL CAGE SYSTEMS AND METHODS FOR DISTRIBUTED TISSUE CONTACT FOR MAPPING AND ABLATION | Non-Final OA | Biosense Webster (Israel) Ltd. |
| 18313708 | ELECTRICAL CONNECTOR FOR A CATHETER DEVICE | Non-Final OA | Biosense Webster (Israel) Ltd. |
| 18990546 | ULTRASONIC TREATMENT TOOL | Final Rejection | OLYMPUS MEDICAL SYSTEMS CORP. |
| 19088877 | RF ABLATION CATHETER FOR TREATING HYPERTROPHIC CARDIOMYOPATHY AND METHOD OF TREATING HYPERTROPHIC CARDIOMYOPATHY BY USING SAME | Non-Final OA | UNIVERSITY OF ULSAN FOUNDATION FOR INDUSTRY COOPERATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy64.8% of resolved applications examined by Jr, Ronald James Hupczey were allowed (821 resolved cases), compared with 0.0% across Art Unit 3739 over the last five years.
This examiner's interview lift is +22.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Jr, Ronald James Hupczey took 1,459 days on average from filing to allowance.
Jr, Ronald James Hupczey examines applications in Art Unit 3739 in Tech Center 3700 (Medical Devices & Mechanical Engineering).
